Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07012148 · ClinicalTrials.gov registry record · NA
Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and Wearables
A NA study of Focal Epilepsy and Generalized Seizure, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT07012148: Recruiting NA study of Focal Epilepsy and Generalized Seizure, sponsored by Mayo Clinic.
NCT07012148 is a NA study of Focal Epilepsy and Generalized Seizure that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 12 participants, below the 171-participant average among 8 other Focal Epilepsy trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07012148, a NA study of Focal Epilepsy and Generalized Seizure, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the safety and feasibility of using seizure forecasts based on subscalp EEG.
Primary Outcome
Number of device-related adverse events during the study period
Conditions Studied
Interventions
- DEVICE UNEEG SubQ device
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2026-01-20 |
| Est. Completion | 2029-12 |
| Phase | NA |
What NCT07012148 shows while recruiting
NCT07012148 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 171-participant average among 8 other Focal Epilepsy trials with a reported enrollment target (93% lower).
The record links to 3 conditions, with Focal Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which UNEEG SubQ device is the first listed.
NCT07012148 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT07012148 about?
NCT07012148 is a clinical study titled "Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and Wearables". The purpose of this study is to evaluate the safety and feasibility of using seizure forecasts based on subscalp EEG.
What is the current status of trial NCT07012148?
This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2026-01-20. Estimated completion is 2029-12.
What conditions does trial NCT07012148 study?
This clinical trial studies the following conditions: Focal Epilepsy, Generalized Seizure, Drug Refractory Epilepsy.
What interventions are being tested in trial NCT07012148?
The interventions under investigation include: UNEEG SubQ device (DEVICE).
Who is sponsoring clinical trial NCT07012148?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07012148 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Focal Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07012148's enrollment target sits among peer trials
12 9th of 8 the lowest of 8 other Focal Epilepsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Focal Epilepsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Diffusion MRI Methods to Minimize Postoperative Deficits in Pediatric Epilepsy Surgery
RECRUITING · NA
-
Breathing Rescue for SUDEP Prevention
RECRUITING · NA
-
Study of Transcranial Direct Current Stimulation to Treat Epilepsy
RECRUITING · NA
-
Sleep Architecture & Cognition in Focal Epilepsy
RECRUITING · NA
-
Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
RECRUITING · Phase 2
-
A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI